238 followers
RT @BloodAdvances: For many patients, Ig is unlikely to provide sufficient health benefits to warrant the additional cost compared with ant…
RT @BloodAdvances: For many patients, Ig is unlikely to provide sufficient health benefits to warrant the additional cost compared with ant…
RT @BloodAdvances: For many patients, Ig is unlikely to provide sufficient health benefits to warrant the additional cost compared with ant…
RT @TalhaBadarMD: Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies h…
RT @BloodAdvances: For many patients, Ig is unlikely to provide sufficient health benefits to warrant the additional cost compared with ant…